Drugs / Octofluoropropane
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| — | NCT02370199 Background | Nov 2014 → Dec 2027 expected | — | University of Alabama at Birmingham | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Octofluoropropane | “Octofluoropropane will be administered as a continuous infusion prior to the initiation of 670 nm light in order to measure skeletal muscle blood flow.” NCT02370199 ↗ |
| Modality | Diagnostic / imaging agent | “continuous infusion of Definity (octafluoropropane) ultrasound contrast” NCT02370199 ↗ |
| Route | Other | “administered as a continuous infusion” NCT02370199 ↗ |